(11:04 GMT) Larimar Therapeutics Price Target Announced at $10.00/Share by HC Wainwright & Co.
DO Dow Jones Newswires Larimar Therapeutics Coverage Assumed by HC Wainwright & Co. at Buy 7/2/2026, 07:04 PM GMT+8 Dow Jones Newswires LR LRMR (11:04 GMT) Larimar Therapeutics Price Target Announced at $10.00/Share by HC Wainwright & Co. Market News Stocktwits LRMR Shares Hold Steady As Wall Street Optimism Offsets Drug Safety Concerns Dow Jones Newswires Larimar Therapeutics Is Maintained at Outperform by Baird Quartr LRMR: Nomlabofusp shows sustained efficacy and safety in FA, with BLA submission and phase III underway Quartr LRMR: Nomlabofusp shows sustained frataxin increases and clinical benefit in Friedreich's ataxia
